NCT06521697View on ClinicalTrials.gov

Effects of Minimal-Flow Sevoflurane and Multimodal Analgesia in Head and Neck Cancer Surgery

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Head and Neck CancerAnesthesiaRenal ProtectionAcute Kidney InjuryMultimodal Analgesia
Interventions
DRUG

Multimodal analgesia using dexmedetomidine-ketamine-lidocaine mixture

Multimodal analgesia using dexmedetomidine-ketamine-lidocaine mixture vs placebo normal saline

DEVICE

Minimal flow sevoflurane

Minimal flow sevoflurane anesthesia (0.5 L/min) vs low flow sevoflurane (1 L/min)

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER